Follow-up of patients with contrast-induced nephropathy.
In this chapter, we review the approach to following the patient after contrast is administered. We first discuss the clinical importance of renal injury for if there were no clinically significant consequences of this renal injury, we would have far less concern for the adequacy of follow-up. We next look at markers of renal injury and what tests are used in clinical practice to define contrast-induced nephropathy (CIN). Finally, we discuss the steps that should be taken in those who do develop CIN to limit the impact of the injury and protect them from future adverse events.
Solomon
R
R
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont 05401, USA. richard.solomon@vtmednet.org
Barrett
B
B
D015415:Biomarkers / Q000032:analysis; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood*; D003956:Dialysis / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000401:mortality / Q000517:prevention & control; D009994:Osmolar Concentration; D017063:Outcome Assessment, Health Care; D012307:Risk Factors
D015415:Biomarkers; D003287:Contrast Media; D003404:Creatinine